Efficacy, Safety of Current Treatments for C. Diff Infection, Recurrent C. Diff Infection

Teena Chopra, MD, MPH, professor of infectious diseases at Wayne State University, discusses the current treatment strategies for C. diff infection and recurrent C. diff infection, as well as the efficacy and safety of these treatments.

Pharmacy Times interviewed Teena Chopra, MD, MPH, professor of infectious diseases at Wayne State University, on her presentation at the American Society of Health-System Pharmacists 2021 Midyear Clinical Meeting on whether the power of the microbiome can be unlocked to break the cycle of recurrent Clostridioides difficile (C. diff) infection.

During the interview, Chopra discussed the current treatment strategies for C. diff infection and recurrent C. diff infection, as well as the efficacy and safety of these treatments.